ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,192.80
      1.78%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      73.94
      2.16%
      Bitcoin
      62,086.87
      0.67%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. EV3 (MM) (EVVV) Quote

      EV3 (MM)

      EV3 (MM) (EVVV)

      NASDAQ
      22.56
      0.00
      (0.00%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      22.56
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      22.56
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      22.56
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      EVVV Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      18 hours ago

      3rd UPDATE: J&J Buying Stroke-Treatment Co Micrus For $480 Million

      (Adds analyst comments on market in paragraphs five and eight.) By Jon Kamp Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) said Monday it plans to bolster its lineup of stroke-prevention...

      July 12 2010
      Dow Jones News

      2nd UPDATE: J&J Buying Stroke-Treatment Co Micrus For $480 Million

      (Adds analyst comment on deal value in seventh paragraph.) By Jon Kamp Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) said Monday it plans to bolster its lineup of stroke-prevention products...

      July 12 2010
      Dow Jones News

      UPDATE: J&J Buying Stroke-Treatment Co Micrus For $480 Million

      (Adds details on deal and competitors throughout; updates share prices.) By Jon Kamp Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) said Monday it plans to bolster its lineup of...

      July 12 2010
      Dow Jones News

      ev3 Inc. Agrees to Settle Stockholder Litigation

      PLYMOUTH, Minn., July 6, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that it has reached an agreement with the plaintiffs to settle the...

      July 06 2010
      GlobeNewswire Inc.

      ev3 Announces Acceptance of Pipeline(TM) Embolization Device

      PLYMOUTH, Minn., June 21, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted...

      June 21 2010
      GlobeNewswire Inc.

      CORRECTING and REPLACING Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Ev3 Inc. by Covidien

      Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: BULL & LIFSHITZ, LLP ANNOUNCES INVESTIGATION OF...

      June 09 2010
      Business Wire

      Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Ev3 Inc. by Covidien

      Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Ev3 Inc.(NASDAQ: EVVV) (referred to as...

      June 09 2010
      Business Wire

      Robbins Umeda LLP Announces an Investigation of the Acquisition of ev3 Inc. by Covidien plc

      Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of ev3 Inc...

      June 02 2010
      Business Wire

      (OTCBB: DTRO) Issues Update on Its Diverse Revenue Streams

      NEW YORK, NY -- (Marketwire) -- 06/02/10 -- Deltron, Inc. (OTCBB: DTRO) announced their corporate update yesterday, giving guidance on both wholly owned subsidiaries Blu Vu Life Support...

      June 02 2010
      Marketwired
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ZEOZeo Energy Corporation
      $ 4.76
      (317.54%)
      		631.91k
      XCURExicure Inc
      $ 7.03
      (206.99%)
      		1.43M
      VEROVenus Concept Inc
      $ 0.9219
      (83.46%)
      		1.64M
      TBIOTelesis Bio Inc
      $ 1.74
      (27.94%)
      		29.79k
      SPISPI Energy Company Ltd
      $ 0.4979
      (27.57%)
      		3.8k
      PGNYProgyny Inc
      $ 18.75
      (-23.28%)
      		14.1k
      VEEAVeea Inc
      $ 10.30
      (-15.92%)
      		9.19k
      WBUYWeBuy Global Ltd
      $ 0.1552
      (-15.79%)
      		194.58k
      RNAZTransCode Therapeutics Inc
      $ 0.3064
      (-12.46%)
      		6.32k
      ALLRAllarity Therapeutics Inc
      $ 2.08
      (-9.57%)
      		4.3k
      FRGTFreight Technologies Inc
      $ 0.155
      (25.10%)
      		6.81M
      VEROVenus Concept Inc
      $ 0.9219
      (83.46%)
      		1.64M
      XCURExicure Inc
      $ 7.03
      (206.99%)
      		1.43M
      SQQQProShares UltraPro Short QQQ
      $ 7.96
      (-5.24%)
      		1.06M
      EJHE Home Household Service Holdings Ltd
      $ 0.112
      (5.66%)
      		900.07k

      EVVV Discussion

      View Posts
      analogdog analogdog 16 years ago
      UPDATE 1-RESEARCH ALERT-Friedman raises Ev3 to outperform
      Mon May 5, 2008 8:17am EDT

      May 5 (Reuters) - Friedman Billings Ramsey upgraded Ev3 Inc (EVVV.O: Quote, Profile, Research) to "outperform" from "market perform," saying the medical device maker's shares should outperform in the next 12 months as the new chief executive executes on turning around the athrectomy business.

      The brokerage, which has a price target of $12 on the stock, said the company's 2008 revenue outlook looks conservative and cost-cutting measures could make Ev3 profitable by the end of 2008.

      Shares of Ev3 closed at $8.71 on Nasdaq Friday, when the company posted a wider-than-expected loss in the first quarter. (Reporting by Aditi Samajpati in Bangalore; Editing by Amitha Rajan)
      👍️0

      Your Recent History

      NASDAQ
      EVVV
      Delayed Upgrade Clock